FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4375861497> ?p ?o ?g. }

• W4375861497 endingPage "112914" @default.
• W4375861497 startingPage "112914" @default.
• W4375861497 abstract "Immunotherapy with checkpoint inhibitors has revolutionised the outcomes for melanoma patients. In the metastatic setting, patients treated with nivolumab and ipilimumab have an expected 5-year survival of> 50%. For patients with resected high-risk stage III disease, adjuvant pembrolizumab, nivolumab or dabrafenib and trametinib are associated with a significant improvement in both relapse-free survival (RFS) and distant metastasis-free survival (DMFS). More recently neoadjuvant immunotherapy has shown very promising outcomes in patients with clinically detectable nodal disease and is likely to become a new standard of care. For stage IIB/C disease, two pivotal adjuvant trials of pembrolizumab and nivolumab have also reported a significant improvement in both RFS and DMFS. However, the absolute benefit is low and there are concerns about the risk of severe toxicities as well as long-term morbidity from endocrine toxicity. Ongoing registration phase III trials are currently evaluating newer immunotherapy combinations and the role of BRAF/MEK-directed targeted therapy for stage II melanoma. However, our ability to personalise therapy based on molecular risk stratification has lagged behind the development of novel immune therapies. There is a critical need to evaluate the use of tissue and blood-based biomarkers, to better select patients that will recur and avoid unnecessary treatment for the majority of patients cured by surgery alone." @default.
• W4375861497 created "2023-05-10" @default.
• W4375861497 creator A5001548963 @default.
• W4375861497 creator A5010492722 @default.
• W4375861497 creator A5052579165 @default.
• W4375861497 creator A5053293132 @default.
• W4375861497 creator A5064026461 @default.
• W4375861497 creator A5069095893 @default.
• W4375861497 creator A5070576000 @default.
• W4375861497 creator A5075441317 @default.
• W4375861497 date "2023-08-01" @default.
• W4375861497 modified "2023-10-15" @default.
• W4375861497 title "Adjuvant therapy for stage II melanoma: the need for further studies" @default.
• W4375861497 cites W2073852133 @default.
• W4375861497 cites W2752210999 @default.
• W4375861497 cites W2752227448 @default.
• W4375861497 cites W2762347490 @default.
• W4375861497 cites W2766764630 @default.
• W4375861497 cites W2797309423 @default.
• W4375861497 cites W2887391891 @default.
• W4375861497 cites W2894796660 @default.
• W4375861497 cites W2921277280 @default.
• W4375861497 cites W2921702329 @default.
• W4375861497 cites W2922851370 @default.
• W4375861497 cites W2947765148 @default.
• W4375861497 cites W2995944038 @default.
• W4375861497 cites W3011435761 @default.
• W4375861497 cites W3029460267 @default.
• W4375861497 cites W3035245749 @default.
• W4375861497 cites W3082456432 @default.
• W4375861497 cites W3087697977 @default.
• W4375861497 cites W3092560521 @default.
• W4375861497 cites W3123792751 @default.
• W4375861497 cites W3127822472 @default.
• W4375861497 cites W3152750473 @default.
• W4375861497 cites W3153228158 @default.
• W4375861497 cites W3159504492 @default.
• W4375861497 cites W3163284774 @default.
• W4375861497 cites W3168935284 @default.
• W4375861497 cites W3169994009 @default.
• W4375861497 cites W3182981660 @default.
• W4375861497 cites W3193637384 @default.
• W4375861497 cites W3206209054 @default.
• W4375861497 cites W3212804507 @default.
• W4375861497 cites W4210370153 @default.
• W4375861497 cites W4221077502 @default.
• W4375861497 cites W4225394054 @default.
• W4375861497 cites W4229079437 @default.
• W4375861497 cites W4281738617 @default.
• W4375861497 cites W4281783912 @default.
• W4375861497 cites W4283029131 @default.
• W4375861497 cites W4283447833 @default.
• W4375861497 cites W4286293529 @default.
• W4375861497 cites W4294100626 @default.
• W4375861497 cites W4295836994 @default.
• W4375861497 cites W4297986245 @default.
• W4375861497 cites W4300772409 @default.
• W4375861497 cites W4308485699 @default.
• W4375861497 cites W4309773737 @default.
• W4375861497 cites W4311104514 @default.
• W4375861497 cites W4313530756 @default.
• W4375861497 cites W4353060526 @default.
• W4375861497 cites W4365514181 @default.
• W4375861497 cites W4381283833 @default.
• W4375861497 doi "https://doi.org/10.1016/j.ejca.2023.05.003" @default.
• W4375861497 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37301717" @default.
• W4375861497 hasPublicationYear "2023" @default.
• W4375861497 type Work @default.
• W4375861497 citedByCount "1" @default.
• W4375861497 countsByYear W43758614972023 @default.
• W4375861497 crossrefType "journal-article" @default.
• W4375861497 hasAuthorship W4375861497A5001548963 @default.
• W4375861497 hasAuthorship W4375861497A5010492722 @default.
• W4375861497 hasAuthorship W4375861497A5052579165 @default.
• W4375861497 hasAuthorship W4375861497A5053293132 @default.
• W4375861497 hasAuthorship W4375861497A5064026461 @default.
• W4375861497 hasAuthorship W4375861497A5069095893 @default.
• W4375861497 hasAuthorship W4375861497A5070576000 @default.
• W4375861497 hasAuthorship W4375861497A5075441317 @default.
• W4375861497 hasBestOaLocation W43758614971 @default.
• W4375861497 hasConcept C121608353 @default.
• W4375861497 hasConcept C126322002 @default.
• W4375861497 hasConcept C143998085 @default.
• W4375861497 hasConcept C184235292 @default.
• W4375861497 hasConcept C2776131300 @default.
• W4375861497 hasConcept C2777658100 @default.
• W4375861497 hasConcept C2777701055 @default.
• W4375861497 hasConcept C2777863537 @default.
• W4375861497 hasConcept C2777982462 @default.
• W4375861497 hasConcept C2778472372 @default.
• W4375861497 hasConcept C2778830669 @default.
• W4375861497 hasConcept C2780030458 @default.
• W4375861497 hasConcept C2780057760 @default.
• W4375861497 hasConcept C2781433595 @default.
• W4375861497 hasConcept C2994587330 @default.
• W4375861497 hasConcept C502942594 @default.
• W4375861497 hasConcept C57074206 @default.
• W4375861497 hasConcept C71924100 @default.

• next